Literature DB >> 18984541

Evidence-based treatment for vasovagal syncope.

Vikas Kuriachan1, Robert S Sheldon, Michael Platonov.   

Abstract

Only a minority of patients with vasovagal syncope require treatment, and most can be managed conservatively. Patients should be encouraged to liberalize their fluid and salt intake, unless they have contraindications such as hypertension. All patients should be taught physical counterpressure maneuvers. Midodrine is the first-line therapy for patients having frequent presyncope or syncope or for those with brief or no prodromes. The routine use of beta-blockers, serotonin-specific reuptake inhibitors, fludrocortisone, and pacemakers is discouraged. Whether loop recorders can be used to target treatment is under investigation, as is fludrocortisone.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18984541     DOI: 10.1016/j.hrthm.2008.08.023

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  7 in total

1.  2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope.

Authors:  Robert S Sheldon; Blair P Grubb; Brian Olshansky; Win-Kuang Shen; Hugh Calkins; Michele Brignole; Satish R Raj; Andrew D Krahn; Carlos A Morillo; Julian M Stewart; Richard Sutton; Paola Sandroni; Karen J Friday; Denise Tessariol Hachul; Mitchell I Cohen; Dennis H Lau; Kenneth A Mayuga; Jeffrey P Moak; Roopinder K Sandhu; Khalil Kanjwal
Journal:  Heart Rhythm       Date:  2015-05-14       Impact factor: 6.343

2.  Treatment of vasovagal syncope: an update.

Authors:  Luciana Armaganijan; Carlos A Morillo
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-10

3.  Cardiac syncope due to pain: report of a case responsive to duloxetine treatment.

Authors:  C Kaplan; S A Kocaman; M E Durakoğlugil; E Kaya; M G Senol
Journal:  Herz       Date:  2013-04-17       Impact factor: 1.443

4.  Comparative Clinical Pharmacokinetics of Midodrine and Its Active Metabolite Desglymidodrine in Cirrhotic Patients with Tense Ascites Versus Healthy Volunteers.

Authors:  Ahmed Ali; Samar Farid; Mona Amin; Mohamed Kassem; Nouman Al-Garem; Medhat Al-Ghobashy
Journal:  Clin Drug Investig       Date:  2016-02       Impact factor: 2.859

5.  Reducing Unnecessary Diagnostic Testing in Pediatric Syncope: A Quality Improvement Initiative.

Authors:  Melissa M Winder; Jennifer Marietta; Lynne M Kerr; Michael D Puchalski; Chong Zhang; Adam L Ware; Collin G Cowley
Journal:  Pediatr Cardiol       Date:  2021-02-13       Impact factor: 1.655

6.  Fludrocortisone in Pediatric Vasovagal Syncope: A Retrospective, Single-Center Observational Study.

Authors:  SeoYeon Yi; Young Hwa Kong; Sun Jun Kim
Journal:  J Clin Neurol       Date:  2021-01       Impact factor: 3.077

Review 7.  Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope.

Authors:  Monica Solbiati; Giorgio Costantino; Giovanni Casazza; Franca Dipaola; Andrea Galli; Raffaello Furlan; Nicola Montano; Robert Sheldon
Journal:  Cochrane Database Syst Rev       Date:  2016-04-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.